Cancer
| Corporate Author: | |
|---|---|
| Other Authors: | |
| Language: | English |
| Published: |
Berlin, Heidelberg :
Springer Berlin Heidelberg : Imprint: Springer,
2007.
|
| Edition: | 1st ed. 2007. |
| Series: | Topics in Medicinal Chemistry,
1 |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/978-3-540-33120-9 |
Table of Contents:
- Overview
- Anti-hormone Therapy: Principles of Endocrine Therapy of Cancer
- Inhibition of Growth Factor Signaling by Small-Molecule Inhibitors of ErbB, Raf, and MEK
- Farnesyl Protein Transferase Inhibitors: Medicinal Chemistry, Molecular Mechanisms, and Progress in the Clinic
- Survival Signaling
- Progress in the Development of Agents to Control the Cell Cycle
- HDAC Inhibition in Cancer Therapy: An Increasingly Intriguing Tale of Chemistry, Biology and Clinical Benefit
- Development of Angiogenesis Inhibitors to Vascular Endothelial Growth Factor Receptor 2 for Cancer Therapy
- Novel Small-Molecule Inhibitors of Src Kinase for Cancer Therapy
- Bcr-Abl Kinase Inhibitors.